DP

Diadema Partners Portfolio holdings

AUM $168M
1-Year Est. Return 163.97%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+163.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$168M
AUM Growth
+$24.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
152
New
Increased
Reduced
Closed

Top Buys

1 +$13.1M
2 +$7.65M
3 +$5.07M
4
UTHR icon
United Therapeutics
UTHR
+$4.66M
5
BBIO icon
BridgeBio Pharma
BBIO
+$4.59M

Top Sells

1 +$13.5M
2 +$8.74M
3 +$8.25M
4
INDV icon
Indivior Pharmaceuticals
INDV
+$7.23M
5
BMY icon
Bristol-Myers Squibb
BMY
+$5.86M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TERN icon
1
Terns Pharmaceuticals
TERN
$4.51B
$14M 8.32%
345,880
+22,721
JNJ icon
2
Johnson & Johnson
JNJ
$595B
$13.8M 8.19%
+66,444
VKTX icon
3
Viking Therapeutics
VKTX
$3.69B
$11.9M 7.06%
336,849
+143,160
ABVX
4
Abivax
ABVX
$8.78B
$10.2M 6.08%
75,644
+34,024
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.2B
$8.7M 5.18%
146,361
-66,516
REGN icon
6
Regeneron Pharmaceuticals
REGN
$81.1B
$7.95M 4.73%
10,300
-19,860
BBIO icon
7
BridgeBio Pharma
BBIO
$12.5B
$5.35M 3.19%
+70,000
UTHR icon
8
United Therapeutics
UTHR
$21.5B
$4.87M 2.9%
+10,000
COGT icon
9
Cogent Biosciences
COGT
$6.04B
$4.68M 2.79%
131,852
+34,039
CAPR icon
10
Capricor Therapeutics
CAPR
$1.41B
$4.56M 2.72%
+158,075
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$120B
$4.53M 2.7%
+10,000
ANIP icon
12
ANI Pharmaceuticals
ANIP
$1.71B
$4.21M 2.51%
53,354
+21,954
TGTX icon
13
TG Therapeutics
TGTX
$4.58B
$3.68M 2.19%
123,283
+62,535
BIOA
14
BioAge Labs
BIOA
$854M
$3.59M 2.14%
+271,164
CORT icon
15
Corcept Therapeutics
CORT
$3.75B
$3.39M 2.02%
+97,445
TENX icon
16
Tenax Therapeutics
TENX
$71.3M
$2.96M 1.77%
+243,170
RVMD icon
17
Revolution Medicines
RVMD
$19.4B
$2.95M 1.76%
37,020
-22,059
IMCR icon
18
Immunocore
IMCR
$1.64B
$2.44M 1.45%
70,300
-54,084
IRWD icon
19
Ironwood Pharmaceuticals
IRWD
$592M
$2.3M 1.37%
+683,611
CNTA
20
Centessa Pharmaceuticals
CNTA
$3.87B
$2.25M 1.34%
+90,000
REPL icon
21
Replimune Group
REPL
$592M
$2.25M 1.34%
+230,997
LLY icon
22
Eli Lilly
LLY
$951B
$2.15M 1.28%
+2,000
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$42.3B
$2.12M 1.26%
5,341
-4,659
LPCN icon
24
Lipocine
LPCN
$46.7M
$2.1M 1.25%
+260,939
PTGX icon
25
Protagonist Therapeutics
PTGX
$5.71B
$1.98M 1.18%
22,700
-28,485